Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in the following investor conferences in November.
BMO Biopharma Spotlight Series: Oncology Day
Date: Wednesday, November 9, 2022
Fireside Chat: 11:30 a.m. ET
Piper Sandler 34th Annual Healthcare Conference
Date: Tuesday, November 29, 2022
Fireside Chat: 8:30 a.m. ET
Location: New York, NY
A live webcast of the Piper Sandler fireside chat will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.
About CytomX Therapeutics
Probody is a U.S. registered trademark of CytomX Therapeutics, Inc.
SVP, Finance and Accounting
Investor and Media Contact:
Stern Investor Relations